Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma
Public ClinicalTrials.gov record NCT01013324. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of XL147 (SAR245408) in Subjects With Advanced or Recurrent Endometrial Carcinoma
Study identification
- NCT ID
- NCT01013324
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Interventions
- XL147 (SAR245408) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2009
- Primary completion
- Feb 28, 2013
- Completion
- Feb 28, 2013
- Last update posted
- Jun 2, 2016
2010 – 2013
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 1526 | Newport Beach | California | 92663 | — |
| Investigational Site Number 1532 | Orlando | Florida | 32806 | — |
| Investigational Site Number 1239 | Augusta | Georgia | 30912 | — |
| Investigational Site Number 1133 | Boston | Massachusetts | 02115 | — |
| Investigational Site Number 1325 | Columbus | Ohio | 43210 | — |
| Investigational Site Number 1434 | Oklahoma City | Oklahoma | 73084 | — |
| Investigational Site Number 1132 | Abington | Pennsylvania | 19001 | — |
| Investigational Site Number 1134 | Philadelphia | Pennsylvania | 19111 | — |
| Investigational Site Number 1142 | Providence | Rhode Island | 02905 | — |
| Investigational Site Number 1527 | Dallas | Texas | 75230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01013324, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2016 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01013324 live on ClinicalTrials.gov.